COMPARE · Data as of October 9, 2026

XPEV vs DORM

Verdict: Side-by-side breakdown using the Bull Rankings model. XPEV scored 25.4, DORM scored 60.6 — DORM leads.
Compare another set
Different reporting periods. DORM's fundamentals are as of June 2026, but XPEV's are as of December 2025 — a 6-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
XPEV
XPeng Inc.
Auto Manufacturers · Quality-Growth
25.4
$9.90 · $9.5B
fundamentals as of
Score gap
35.2
DORM leads
DORM
Dorman Products, Inc.
Auto Parts · Quality-Growth
60.6
$120.40 · $3.6B
fundamentals as of
  • Fastest growthXPEV+87.7%
  • Strongest balance sheetDORM0.35
  • Highest qualityDORM73 / 100
  • Largest discount to fair valueXPEV-41%
THE BULL RANKINGS SCORECARD25.4/ 100 · BULL SCOREPEER MEDIANQUALITY27.9GROWTH50.0VALUE21.4
THE BULL RANKINGS SCORECARD60.6/ 100 · BULL SCOREPEER MEDIANQUALITY72.5GROWTH50.0VALUE61.3
XPEVDORMQuality27.972.5Growth50.050.0Value21.461.3
FCFXPEV$735mDORM$214m
RevXPEV+87.7%DORM+6.0%
D/EXPEV0.99DORM0.35
XPEV
stronger →← stronger
DORM
28
Qualityreturns · margins · balance sheet
73
50
Growthrevenue & earnings expansion
50
21
Valuevaluation vs sector peers
61
DORM is stronger on 2 of 3 pillars.
XPEV
DORM
$735mC+
FCF
$214mC
+87.7%A
Rev
+6.0%C+
0.99B
D/E
0.35A-
0.8xB+
P/S
—
—
PEG
1.17B+
—
P/E
16.7xB
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
XPEV
DORM
41% below
Price vs fair valuelower is cheaper
8% above
~2%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~7%/yr
+31%
1-yr DCF upside
-10%
+71%
5-yr DCF upside
-8%
+150%
10-yr DCF upside
-4%
These two disagree on this pair: the Value pillar ranks cheapness against sector peers, while price-vs-fair-value is an absolute read. A name can be the better value in its sector and still the dearer one on cash flows.
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
XPEV
Why this score
  • Cyclical growth
  • Foreign reporter (CNY)
DORM
Why this score
  • Buying back stock
  • Durable high returns
  • Cyclical growth
XPEVXPeng Inc.
Auto Manufacturers · $9.90 · beta 1.07
Why now
Auto Manufacturers · market cap $9.5b. Down 65% from 52-week high of $28.23 — deep drawdown territory. Revenue growing +88% — in hypergrowth territory. 25 sell-side analysts rate this a Buy with a mean 1-yr target of $18.46 (implying +86% upside).
Moat
Turnaround / out-of-favor name — GAAP-unprofitable for now, so the durability case is forward-looking: it rests on a recovery (margin normalization, a cyclical upturn or restructuring) or an un-monetized asset (IP / network effects / first-mover position) rather than on current reported results.
Risk
Currently unprofitable (margin -1.5%) — path to GAAP profitability is the core thesis risk. Down 65% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. ROE -4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
DORMDorman Products, Inc.
Auto Parts · $120.40 · beta 1.02
Why now
Auto Parts · market cap $3.6b. Down 27% from 52-week high of $164.00 — deep drawdown territory. 8 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $161.63 (implying +34% upside).
Moat
ROE 15% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 98% of net income — earnings translate cleanly into cash.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where XPEV and DORM diverge

On the headline score the gap is 35.2 points in favor of DORM. The widest single difference is Quality, where DORM leads by 44.6 points.

Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.

Common questions

Is DORM or XPEV the better stock?

DORM scores higher: DORM 60.6, XPEV 25.4 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.

Where do DORM and XPEV differ most?

The widest gap is quality, where DORM leads by 45 points on the 0–100 pillar scale. DORM also leads value, while growth is effectively level between them.

How are DORM and XPEV scored?

Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.

How current is this comparison?

The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.